These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Incidence, predictors and outcomes of device-related thrombus after left atrial appendage closure with the WATCHMAN device-Insights from the EWOLUTION real world registry. Sedaghat A; Nickenig G; Schrickel JW; Ince H; Schmidt B; Protopopov AV; Betts TR; Gori T; Sievert H; Mazzone P; Grygier M; Wald C; Vireca E; Allocco D; Boersma LVA; Catheter Cardiovasc Interv; 2021 Jun; 97(7):E1019-E1024. PubMed ID: 33417282 [TBL] [Abstract][Full Text] [Related]
9. Predictors of thrombus formation after percutaneous left atrial appendage closure using the WATCHMAN device. Kaneko H; Neuss M; Weissenborn J; Butter C Heart Vessels; 2017 Sep; 32(9):1137-1143. PubMed ID: 28477098 [TBL] [Abstract][Full Text] [Related]
10. Overcoming barriers for left atrial appendage thrombus: a systematic review of left atrial appendage closure. Zhang Z; Zhou J; Lin Q; Wang C; Huang Y; Dai Y; Zuo W; Liu N; Xiao Y; Liu Q BMC Cardiovasc Disord; 2024 Mar; 24(1):175. PubMed ID: 38515032 [TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of different anticoagulation regimens after left atrial appendage occlusion. Li W; Gao R; Zhao J; Ren Y; Chen G; Zhu J; Jin K; Zhu L; Ruan Z Ann Palliat Med; 2022 Jan; 11(1):201-209. PubMed ID: 35144411 [TBL] [Abstract][Full Text] [Related]
12. Cerebrovascular events, bleeding complications and device related thrombi in atrial fibrillation patients with chronic kidney disease and left atrial appendage closure with the WATCHMAN™ device. Luani B; Genz C; Herold J; Mitrasch A; Mitusch J; Wiemer M; Schmeißer A; Braun-Dullaeus RC; Rauwolf T BMC Cardiovasc Disord; 2019 May; 19(1):112. PubMed ID: 31092201 [TBL] [Abstract][Full Text] [Related]
13. Short-term non-vitamin K antagonist oral anticoagulants vs. warfarin in preventing device-related thrombosis after left atrial appendage closure. Chen Y; Zhang Y; Qu L; Huang W; Su X; Chen Y J Thromb Thrombolysis; 2021 Oct; 52(3):872-879. PubMed ID: 33666825 [TBL] [Abstract][Full Text] [Related]
14. Short-term antiplatelet versus anticoagulant therapy after left atrial appendage closure: a systematic review and meta-analysis. Zhou Q; Liu X; Gu ZC; Yang X; Huang XH; Wu YZ; Tao YY; Wei M J Thromb Thrombolysis; 2024 Feb; 57(2):194-203. PubMed ID: 38180590 [TBL] [Abstract][Full Text] [Related]
15. Assessment of Device-Related Thrombus and Associated Clinical Outcomes With the WATCHMAN Left Atrial Appendage Closure Device for Embolic Protection in Patients With Atrial Fibrillation (from the PROTECT-AF Trial). Main ML; Fan D; Reddy VY; Holmes DR; Gordon NT; Coggins TR; House JA; Liao L; Rabineau D; Latus GG; Huber KC; Sievert H; Wright RF; Doshi SK; Douglas PS Am J Cardiol; 2016 Apr; 117(7):1127-34. PubMed ID: 26993976 [TBL] [Abstract][Full Text] [Related]
16. Watchman FLX vs. Watchman 2.5 in a Dual-Center Left Atrial Appendage Closure Cohort: the WATCH-DUAL study. Galea R; Mahmoudi K; Gräni C; Elhadad S; Huber AT; Heg D; Siontis GCM; Brugger N; Sebag F; Windecker S; Valgimigli M; Landolff Q; Roten L; Amabile N; Räber L Europace; 2022 Oct; 24(9):1441-1450. PubMed ID: 35253840 [TBL] [Abstract][Full Text] [Related]
17. Incidence and Clinical Impact of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion: A Meta-Analysis. Alkhouli M; Busu T; Shah K; Osman M; Alqahtani F; Raybuck B JACC Clin Electrophysiol; 2018 Dec; 4(12):1629-1637. PubMed ID: 30573129 [TBL] [Abstract][Full Text] [Related]
18. Device Thrombosis After Percutaneous Left Atrial Appendage Occlusion Is Related to Patient and Procedural Characteristics but Not to Duration of Postimplantation Dual Antiplatelet Therapy. Pracon R; Bangalore S; Dzielinska Z; Konka M; Kepka C; Kruk M; Kaczmarska-Dyrda E; Petryka-Mazurkiewicz J; Bujak S; Solecki M; Pskit A; Dabrowska A; Sieradzki B; Plonski A; Ruzyllo W; Witkowski A; Demkow M Circ Cardiovasc Interv; 2018 Mar; 11(3):e005997. PubMed ID: 29463510 [TBL] [Abstract][Full Text] [Related]
19. Persistent and Recurrent Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes. Mesnier J; Simard T; Jung RG; Lehenbauer KR; Piayda K; Pracon R; Jackson GG; Flores-Umanzor E; Faroux L; Korsholm K; Chun JKR; Chen S; Maarse M; Montrella K; Chaker Z; Spoon JN; Pastormerlo LE; Meincke F; Sawant AC; Moldovan CM; Qintar M; Aktas MK; Branca L; Radinovic A; Ram P; El-Zein RS; Flautt T; Ding WY; Sayegh B; Benito-González T; Lee OH; Badejoko SO; Paitazoglou C; Karim N; Zaghloul AM; Agarwal H; Kaplan RM; Alli O; Ahmed A; Suradi HS; Knight BP; Alla VM; Panaich SS; Wong T; Bergmann MW; Chothia R; Kim JS; Pérez de Prado A; Bazaz R; Gupta D; Valderrábano M; Sanchez CE; El Chami MF; Mazzone P; Adamo M; Ling F; Wang DD; O'Neill W; Wojakowski W; Pershad A; Berti S; Spoon DB; Kawsara A; Jabbour G; Boersma LVA; Schmidt B; Nielsen-Kudsk JE; Freixa X; Ellis CR; Fauchier L; Demkow M; Sievert H; Main ML; Hibbert B; Holmes DR; Alkhouli M; Rodés-Cabau J JACC Cardiovasc Interv; 2023 Nov; 16(22):2722-2732. PubMed ID: 38030358 [TBL] [Abstract][Full Text] [Related]
20. Comparison of cardiac computed tomography angiography and transoesophageal echocardiography for device surveillance after left atrial appendage closure. Qamar SR; Jalal S; Nicolaou S; Tsang M; Gilhofer T; Saw J EuroIntervention; 2019 Oct; 15(8):663-670. PubMed ID: 31217149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]